Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib Regimens in Multiple Basal Cell Carcinomas
NCT01815840Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of vismodegib in basal cell carcinoma (BCC), sponsored by Roche. Started Apr 2013; status: completed.
02
Drugs
vismodegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01815840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815840.